1. Home
  2. RLYB vs UG Comparison

RLYB vs UG Comparison

Compare RLYB & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rallybio Corporation

RLYB

Rallybio Corporation

N/A

Current Price

$8.67

Market Cap

28.7M

Sector

Health Care

ML Signal

N/A

Logo United-Guardian Inc.

UG

United-Guardian Inc.

N/A

Current Price

$6.25

Market Cap

30.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
RLYB
UG
Founded
2018
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.7M
30.2M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
RLYB
UG
Price
$8.67
$6.25
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
263.8K
2.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
7.99%
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$858,000.00
$12,181,971.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$32.40
Revenue Growth
43.00
11.91
52 Week Low
$0.22
$5.58
52 Week High
$11.49
$9.88

Technical Indicators

Market Signals
Indicator
RLYB
UG
Relative Strength Index (RSI) 57.69 40.87
Support Level $0.48 $5.58
Resistance Level $11.49 $6.78
Average True Range (ATR) 0.69 0.13
MACD -0.41 -0.03
Stochastic Oscillator 0.38 21.92

Price Performance

Historical Comparison
RLYB
UG

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: